SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol

SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol

Background: Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the ma...

Full description

Bibliographic Details
Main Authors: Jay Patel, BS, Hammad Sadiq, BS, John Catanzaro, MD, FHRS, Sybil Crawford, PhD, Adam Wright, PhD, Gordon Manning, MD, Jeroan Allison, MD, MSc, Kathleen Mazor, EdD, David McManus, MD, MSc, FHRS, Alok Kapoor, MD, MSc
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Cardiovascular Digital Health Journal
Subjects:
Anticoagulation
Atrial fibrillation
Clinical decision support
Clinical trials
Electronic medical records
Online Access:http://www.sciencedirect.com/science/article/pii/S2666693621000591

Internet

http://www.sciencedirect.com/science/article/pii/S2666693621000591

Similar Items